Citation
De Martinis, Massimo, et al. "Hyperhomocysteinemia Is Associated With Inflammation, Bone Resorption, Vitamin B12 and Folate Deficiency and MTHFR C677T Polymorphism in Postmenopausal Women With Decreased Bone Mineral Density." International Journal of Environmental Research and Public Health, vol. 17, no. 12, 2020.
De Martinis M, Sirufo MM, Nocelli C, et al. Hyperhomocysteinemia is Associated with Inflammation, Bone Resorption, Vitamin B12 and Folate Deficiency and MTHFR C677T Polymorphism in Postmenopausal Women with Decreased Bone Mineral Density. Int J Environ Res Public Health. 2020;17(12).
De Martinis, M., Sirufo, M. M., Nocelli, C., Fontanella, L., & Ginaldi, L. (2020). Hyperhomocysteinemia is Associated with Inflammation, Bone Resorption, Vitamin B12 and Folate Deficiency and MTHFR C677T Polymorphism in Postmenopausal Women with Decreased Bone Mineral Density. International Journal of Environmental Research and Public Health, 17(12). https://doi.org/10.3390/ijerph17124260
De Martinis M, et al. Hyperhomocysteinemia Is Associated With Inflammation, Bone Resorption, Vitamin B12 and Folate Deficiency and MTHFR C677T Polymorphism in Postmenopausal Women With Decreased Bone Mineral Density. Int J Environ Res Public Health. 2020 06 15;17(12) PubMed PMID: 32549258.
TY - JOUR
T1 - Hyperhomocysteinemia is Associated with Inflammation, Bone Resorption, Vitamin B12 and Folate Deficiency and MTHFR C677T Polymorphism in Postmenopausal Women with Decreased Bone Mineral Density.
AU - De Martinis,Massimo,
AU - Sirufo,Maria Maddalena,
AU - Nocelli,Cristina,
AU - Fontanella,Lara,
AU - Ginaldi,Lia,
Y1 - 2020/06/15/
PY - 2020/05/12/received
PY - 2020/06/10/revised
PY - 2020/06/12/accepted
PY - 2020/6/19/entrez
PY - 2020/6/19/pubmed
PY - 2020/10/7/medline
KW - MTHFR
KW - bone
KW - bone mineral density
KW - folate
KW - hyperhomocysteinemia
KW - inflammation
KW - osteoporosis
KW - postmenopausal women
KW - vitamin B12
KW - vitamin D
JF - International journal of environmental research and public health
JO - Int J Environ Res Public Health
VL - 17
IS - 12
N2 - Osteoporosis is an age-related bone disease, affecting mainly postmenopausal women, characterized by decreased bone mineral density (BMD) and consequent risk of fractures. Homocysteine (Hcy), a sulfur-aminoacid whose serum level is regulated by methylenetrahydrofolate reductase (MTHFR) activity and vitamin B12 and folate as cofactors, is a risk factor for inflammatory diseases. Literature data concerning the link between Hcy and osteoporosis are still debated. The aim of our study was to assess the relationship among Hcy and BMD, inflammation, vitamin status and bone turnover in postmenopausal osteoporosis. In 252 postmenopausal women, BMD was measured by dual-energy X-ray absorptiometry (DXA). In addition to serum Hcy, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP) and bone turnover markers (bone alkaline phosphatase-BAP, osteocalcin-OC, C-terminal telopeptide of type I collagen (CTX), vitamin deficiencies and MTHFR-C677T polymorphism were evaluated. Hcy, inflammation, bone resorption markers and prevalence of C677T polymorphism were higher, whereas vitamin D, B12, folate, and bone formation markers were lower in women with decreased BMD compared to those with normal BMD. Our results suggest a significant association between Hcy, BMD and inflammation in postmenopausal osteoporosis. The regulation of Hcy overproduction and the modulation of the inflammatory substrate could represent additional therapeutic approaches for osteoporosis prevention.
SN - 1660-4601
UR - https://www.unboundmedicine.com/medline/citation/32549258/Hyperhomocysteinemia_is_Associated_with_Inflammation_Bone_Resorption_Vitamin_B12_and_Folate_Deficiency_and_MTHFR_C677T_Polymorphism_in_Postmenopausal_Women_with_Decreased_Bone_Mineral_Density_
DB - PRIME
DP - Unbound Medicine
ER -